Domača stranBBN • SWX
add
Bellevue Group AG
Prejšnji trg. dan.
14,75 CHF
Dnevni razpon
14,50 CHF - 14,80 CHF
Letni razpon
11,05 CHF - 24,30 CHF
Tržna kapitalizacija
195,19 mio. CHF
Povprečni obseg
9,95 tis.
Razm. P/E
13,08
Dividendna donosnost
7,93 %
Primarna borza
SWX
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(CHF) | jun. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 18,41 mio. | −11,31 % |
Stroški poslovanja | 13,73 mio. | −10,56 % |
Čisti dohodek | 3,72 mio. | −7,22 % |
Čista dobičkovnost prihodkov | 20,18 | 4,61 % |
Earnings per share | — | — |
EBITDA | — | — |
Efektivna davčna stopnja | 17,26 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(CHF) | jun. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 30,49 mio. | 100,63 % |
Skupna sredstva | 138,75 mio. | −4,69 % |
Skupne obveznosti | 22,05 mio. | −24,81 % |
Celoten lastniški kapital | 116,70 mio. | — |
Shares outstanding | 13,20 mio. | — |
Razmerje P/B | 1,67 | — |
Donosnost sredstev | 10,71 % | — |
Donosnost kapitala | — | — |
Denarni tok
Neto sprememba denarnih sredstev
(CHF) | jun. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 3,72 mio. | −7,22 % |
Denar iz dejavnosti | 3,65 mio. | 137,31 % |
Denar iz naložb | — | — |
Denar iz financiranja | −8,10 mio. | 45,85 % |
Neto sprememba denarnih sredstev | −4,17 mio. | 83,13 % |
Prost denarni tok | — | — |
Vizitka
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Generalni direktor
Datum ustanovitve
1993
Spletno mesto
Zaposleni
88